Mod GRF, Ipamorelin, GHRP-2 (Blend)
$95.00
PRODUCT SHORT DESCRIPTION
The Mod GRF, Ipamorelin & GHRP-2 research blend integrates three distinct growth hormone secretagogues to model multi-receptor regulation within the somatotropic axis. This formulation provides a comprehensive biochemical tool for investigating maximum growth hormone pulsatility and receptor signaling crosstalk.
The Mod GRF, Ipamorelin & GHRP-2 Blend is a sophisticated, multi-component research peptide formulation integrating three distinct growth hormone secretagogues into a single, uniform lyophilized matrix. Supplied at โฅ98% purity, this triple-pathway blend is available exclusively at The Peptide Store as a precision biochemical tool for advanced endocrinological and somatotropic axis research. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
The Mod GRF, Ipamorelin & GHRP-2 Blend is engineered to provide research laboratories with a comprehensive, synergistic platform for investigating multi-receptor growth hormone regulation. By combining a Growth Hormone-Releasing Hormone (GHRH) analog with two structurally distinct Growth Hormone Secretagogue Receptor (GHSR) agonists, this formulation enables simultaneous modeling of triple-pathway receptor signaling crosstalk within the somatotropic axis. This integrated presentation eliminates compounding weighing variables and streamlines experimental workflows in high-resolution endocrinology studies.
Peptide Structure & Amino Acid Sequence
This blend incorporates three well-characterized peptide compounds, each with a defined primary sequence and receptor target profile:
- Mod GRF (1-29) โ A truncated, stabilized analog of endogenous GHRH. Its 29-amino acid sequence is modified at key positions to resist enzymatic degradation while preserving full GHRH receptor (GHRHR) agonist activity, enabling sustained stimulation of pituitary somatotrophs.
- Ipamorelin โ A selective pentapeptide GHSR agonist (His-Aib-Trp-D-Phe-Lys-NHโ) notable for its high receptor selectivity and minimal off-target secretagogue activity, making it a valuable research comparator compound.
- GHRP-2 (Pralmorelin) โ A synthetic hexapeptide GHSR agonist (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NHโ) recognized for potent, dose-dependent GH pulse amplification and established use in neuroendocrine signaling studies.
The co-formulation of these three agents in a single lyophilized matrix allows researchers to investigate synchronized receptor activation, competitive binding kinetics, and downstream signal transduction cascades simultaneously.
Chemical & Physical Characteristics
- Formulation Type: Triple-component lyophilized peptide blend
- Physical State: White to off-white lyophilized cake or powder
- Solubility: Soluble in aqueous buffers; refer to laboratory-grade reconstitution protocols for research applications
- Stability: Stable under recommended storage conditions; lyophilized form maximizes long-term integrity
- Molecular Composition: Three distinct peptide sequences co-lyophilized into a single uniform matrix
Purity & Analytical Verification (HPLC & MS)
Each production batch of the Mod GRF, Ipamorelin & GHRP-2 Blend undergoes rigorous analytical verification to confirm identity, purity, and compositional integrity. All three peptide components are independently validated at โฅ98% purity prior to blending. Final batch release is contingent upon passing both High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis, ensuring accurate molecular weight confirmation and absence of significant impurities or degradation byproducts. Certificates of Analysis (CoA) reflecting these results are available for qualified research purchasers upon request.
Quality Control & Lyophilization Integrity
The lyophilization process employed for this blend is conducted under controlled pharmaceutical-grade conditions to preserve the structural integrity and bioactivity profile of all three peptide components. Lyophilization removes residual moisture to levels that minimize hydrolytic degradation during storage and transit. Each vial is sealed under inert conditions to prevent oxidative exposure. Batch-level quality control protocols encompass identity testing, purity profiling, and physical appearance inspection prior to release for distribution.
Safety, Handling & Laboratory Precautions
This product is intended solely for use by qualified research scientists in properly equipped laboratory settings. Standard laboratory personal protective equipment (PPE) โ including gloves, eye protection, and appropriate lab attire โ should be worn when handling lyophilized peptide material. Researchers should consult applicable institutional biosafety guidelines and Material Safety Data Sheets (MSDS) before use. This blend is not approved for any in vivo, clinical, or consumptive application.
Reconstitution, Packaging & Storage
The Mod GRF, Ipamorelin & GHRP-2 Blend is supplied as a lyophilized solid in sealed research-grade vials. Reconstitution should be performed using sterile, laboratory-grade solvents appropriate to the specific in vitro research protocol being conducted. Upon reconstitution, solutions should be aliquoted promptly and stored according to established laboratory best practices. Lyophilized product should be stored at -20ยฐC or below, protected from light and moisture, to maintain maximum stability. Avoid repeated freeze-thaw cycles of reconstituted solutions.
Intended Research Use & Market Positioning
The Mod GRF, Ipamorelin & GHRP-2 Blend is specifically positioned as a high-value research tool for endocrinology laboratories, academic institutions, and pharmaceutical research organizations investigating somatotropic axis regulation, GH pulsatility modeling, neuroendocrine feedback mechanisms, and multi-receptor secretagogue crosstalk. The pre-blended, single-vial format offers a distinct logistical advantage over sourcing and weighing individual components separately, reducing experimental variability and preparation time. This product is not intended, marketed, or sold for any therapeutic, clinical, or personal use purpose.
Ordering, Availability & Fulfillment
The Peptide Store offers the Mod GRF, Ipamorelin & GHRP-2 Blend for sale online with secure ordering, competitive best-price positioning, and reliable fulfillment for qualified research buyers. Order now through our streamlined eCommerce platform to take advantage of fast dispatch, discreet research-grade packaging, and dedicated customer support. Bulk research quantities and institutional procurement inquiries are welcomed โ contact our team for volume pricing details.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Mod GRF, Ipamorelin & GHRP-2 Blend is sold exclusively as a laboratory research reagent. It has not been evaluated by any regulatory authority for safety or efficacy in humans or animals. The Peptide Store makes no therapeutic claims regarding this product. All purchasers are solely responsible for ensuring compliance with applicable local, national, and international laws and regulations governing the purchase, possession, and use of research peptides. This product must not be used in any manner inconsistent with its research-only designation.
Related products
CJC-1295 (No DAC), GHRP-6 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and GHRP-6 formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (no DAC), Hexarelin 10mg (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC and Hexarelin formulation delivers an advanced, dual-action 10mg (10000mcg) research blend combining two synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and growth hormone secretagogue receptor mechanics.
CJC-1295 (No DAC), Ipamorelin, GHRP-2 (Blend)
PRODUCT SHORT DESCRIPTION
The CJC-1295 No DAC, Ipamorelin, and GHRP-2 formulation delivers an advanced, triple-action research blend combining three synergistic synthetic peptides in a single vial. This ratio is engineered strictly for investigating dual-receptor somatotroph coordination, optimized growth hormone (GH) pulsatility curves, and distinct growth hormone secretagogue receptor signaling mechanics.
CJC-1295 No DAC (Modified GRF 1-29)+ Ipamorelin 10mg Blend
CJC-1295 No DAC Ipamorelin 10mg Blend 5mg CJC-1295 No DAC (Modified GRF 1-29) + 5mg Ipamorelin per vial. Lyophilised powder, dual-compound. โฅ99% purity by HPLC. Third-party tested Janoshik Analytical. Heavy metals & endotoxin screened. COA verified per batch. USA-manufactured. $95.00ย In stock. For laboratory research use only.
GHRP-2 (5mg x 10) Ipamorelin (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-2 (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
IGF-1 LR3 1mg
PRODUCT SHORT DESCRIPTION
IGF-1 LR3 1mg is a premium, high-potency synthetic 83-amino-acid analog of human Insulin-like Growth Factor-1. Featuring an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, this 1000mcg configuration is engineered strictly for investigating sustained somatotropic signaling and uninhibited receptor binding kinetics.
Ipamorelin (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The Ipamorelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of Ipamorelin alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.

Reviews
There are no reviews yet.